These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27681618)

  • 1. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.
    Boll JM; Crofts AA; Peters K; Cattoir V; Vollmer W; Davies BW; Trent MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6228-E6237. PubMed ID: 27681618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Septal Class A Penicillin-Binding Protein Activity and ld-Transpeptidases Mediate Selection of Colistin-Resistant Lipooligosaccharide-Deficient Acinetobacter baumannii.
    Kang KN; Kazi MI; Biboy J; Gray J; Bovermann H; Ausman J; Boutte CC; Vollmer W; Boll JM
    mBio; 2021 Jan; 12(1):. PubMed ID: 33402533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine.
    Henry R; Vithanage N; Harrison P; Seemann T; Coutts S; Moffatt JH; Nation RL; Li J; Harper M; Adler B; Boyce JD
    Antimicrob Agents Chemother; 2012 Jan; 56(1):59-69. PubMed ID: 22024825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acinetobacter baumannii Can Survive with an Outer Membrane Lacking Lipooligosaccharide Due to Structural Support from Elongasome Peptidoglycan Synthesis.
    Simpson BW; Nieckarz M; Pinedo V; McLean AB; Cava F; Trent MS
    mBio; 2021 Dec; 12(6):e0309921. PubMed ID: 34844428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin Dependence in Extensively Drug-Resistant
    Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lytic transglycosylase contributes to the survival of lipooligosaccharide-deficient, colistin-dependent Acinetobacter baumannii.
    Lee JY; Lee H; Park M; Cha CJ; Shin D; Ko KS
    Clin Microbiol Infect; 2019 Sep; 25(9):1156.e1-1156.e7. PubMed ID: 30790686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
    Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii.
    Park YK; Lee JY; Ko KS
    Clin Microbiol Infect; 2015 Aug; 21(8):765.e1-7. PubMed ID: 25911992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PmrAB, the two-component system of
    Yamada N; Kamoshida G; Shiraishi T; Yamaguchi D; Matsuoka M; Yamauchi R; Kanda N; Kamioka R; Takemoto N; Morita Y; Fujimuro M; Yokota S-i; Yahiro K
    J Bacteriol; 2024 May; 206(5):e0043523. PubMed ID: 38661375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.
    Soon RL; Nation RL; Cockram S; Moffatt JH; Harper M; Adler B; Boyce JD; Larson I; Li J
    J Antimicrob Chemother; 2011 Jan; 66(1):126-33. PubMed ID: 21081544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
    Moffatt JH; Harper M; Harrison P; Hale JD; Vinogradov E; Seemann T; Henry R; Crane B; St Michael F; Cox AD; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4971-7. PubMed ID: 20855724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.
    Sun B; Liu H; Jiang Y; Shao L; Yang S; Chen D
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32238571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
    Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin Resistance in
    Hua X; Liu L; Fang Y; Shi Q; Li X; Chen Q; Shi K; Jiang Y; Zhou H; Yu Y
    Front Cell Infect Microbiol; 2017; 7():45. PubMed ID: 28275586
    [No Abstract]   [Full Text] [Related]  

  • 18. Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.
    Dafopoulou K; Xavier BB; Hotterbeekx A; Janssens L; Lammens C; Dé E; Goossens H; Tsakris A; Malhotra-Kumar S; Pournaras S
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1892-5. PubMed ID: 26666921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Study of
    Leung LM; McElheny CL; Gardner FM; Chandler CE; Bowler SL; Mettus RT; Spychala CN; Fowler EL; Opene BNA; Myers RA; Goodlett DR; Doi Y; Ernst RK
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.